Anders Fink Vadsholt
Corporate Officer/Principal bei Alpha Healthcare Investments ApS
Ursprung des Netzwerks ersten Grades von Anders Fink Vadsholt
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
1
| Holding Company | Pharmaceuticals: Generic | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anders Fink Vadsholt
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ROVSING A/S | Information Technology Services | Director/Board Member Chairman Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| BIOTAGE AB | Medical Specialties | Director of Finance/CFO | |
| SCANDINAVIAN INVESTMENT GROUP A/S | Real Estate Investment Trusts | Director/Board Member Chief Executive Officer | |
Rodenstock GmbH
 Rodenstock GmbH Medical SpecialtiesHealth Technology Rodenstock GmbH engages in the design, manufacture and market of ophthalmic lenses and frames. It offers progressive lenses, computer glasses, distance glasses, driving glasses, reading glasses, sports glasses, children’s glasses, and sunglasses. The company was founded by Josef Rodenstock and Michael Rodenstock in 1877 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree | |
| ABLYNX | Biotechnology | Chairman Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Technical University of Denmark | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rodenstock Holding GmbH
 Rodenstock Holding GmbH Medical SpecialtiesHealth Technology Part of Rodenstock GmbH, Rodenstock Holding GmbH is a company based in Munich, Germany. The CEOs of the German company are Oliver Kastalio, Marcus Enrico Desimoni, Anders Hedegaard, Roland Dimbath. | Medical Specialties | Chief Executive Officer | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Chairman Chief Executive Officer | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
Foss A/S
 Foss A/S Electronic Equipment/InstrumentsElectronic Technology Foss A/S provides analytical instruments for the food, agricultural, chemical and pharmaceutical industries. It serves biofuel, central milk testing, feed and forage industries. The company was founded by Nils Utke Foss in 1956 and is headquartered in Hillerod, Denmark.. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Glaxosmithkline Investments Pty Ltd.
 Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company. | Pharmaceuticals: Major | Sales & Marketing | |
Intomics A/S
 Intomics A/S Miscellaneous Commercial ServicesCommercial Services Intomics A/S provides data analysis solutions to data intensive research projectsa. Its services include advisory service, data analysis, and knowledge management. The firm helps clients in the pharmaceutical industry discover novel and drug targets, identify innovative and discriminative biomarkers, and enhance understanding of the underlying disease-biology at molecular level. The company was founded by Soren Brunak, Kasper Lage, Rasmus Wernersson and Thomas Skot Jensen in 2008 and is headquartered in Kongens Lyngby, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member | |
Confederation of Danish Industry
 Confederation of Danish Industry Miscellaneous Commercial ServicesCommercial Services Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Ellab A/S
 Ellab A/S Electronic Equipment/InstrumentsElectronic Technology Ellab A/S engages in the provision of process validation and monitoring solutions used in the pharmaceutical, medical, and food industries. It offers calibration, training and consulting, qualification and validation, rental, and software support services. The company was founded by Jorgen Leo Nielsen in 1949 and is headquartered in Hillerod, Denmark. | Electronic Equipment/Instruments | Chairman | |
Bankinvest Biomedical Venture
 Bankinvest Biomedical Venture Investment ManagersFinance Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark. | Investment Managers | Corporate Officer/Principal | |
Eyewear Holding GmbH
 Eyewear Holding GmbH Financial ConglomeratesFinance Eyewear Holding GmbH is an investment holding German company. The private company is based in Munich, Germany. The company was founded in 2006 and has three CEOs\: Marcus Enrico Desimoni, Anders Hedegaard, and Roland Dimbath. | Financial Conglomerates | Chief Executive Officer | |
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Investment Managers | Corporate Officer/Principal | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
Aktieselskabet af 1. juni 2011 II
 Aktieselskabet af 1. juni 2011 II Financial ConglomeratesFinance Part of Bavarian Nordic A/S, Aktieselskabet af 1. juni 2011 II functions as an investment holding Danish company. The company is based in Kvistgard, Denmark. | Financial Conglomerates | Chairman | |
WoB Holding ApS
 WoB Holding ApS Financial ConglomeratesFinance WoB Holding ApS is an investment holding Danish company. The private company is based in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
Oz Holding ApS
 Oz Holding ApS Financial ConglomeratesFinance Oz Holding ApS provides investment services. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Nordic Compound Invest A/S | Chief Executive Officer Director/Board Member | ||
FalCom A/S
 FalCom A/S Medical SpecialtiesHealth Technology Part of GN Store Nord A/S, FalCom A/S is a Danish company that manufactures hearing aids and parts. The company is based in Ballerup, Denmark. | Medical Specialties | Director/Board Member | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Muna Therapeutics ApS
 Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Chief Operating Officer | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aloop Therapeutics ApS
 Aloop Therapeutics ApS Pharmaceuticals: MajorHealth Technology Aloop Therapeutics ApS manufactures pharmaceutical preparations. The company is based in Copenhagen, Denmark. The CEOs are Søren Sylvester Skjærbæk, Thomas Kirkegaard Jensen. The Danish company was founded in 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
Rodenstock Beteiligungen Ausland GmbH
 Rodenstock Beteiligungen Ausland GmbH Miscellaneous Commercial ServicesCommercial Services Part of Rodenstock GmbH, Rodenstock Beteiligungen Ausland GmbH is a German company that provides management services. The company is based in Munich, Germany. The CEOs of the company are Anders Hedegaard, Antonio Arrigoni, Michael Kleer. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistik
International
| Dänemark | 25 |
| Schweden | 5 |
| Deutschland | 5 |
| Niederlande | 5 |
| Vereinigte Staaten | 4 |
Sektoral
| Health Technology | 27 |
| Finance | 10 |
| Commercial Services | 6 |
| Consumer Services | 5 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 155 |
| Chairman | 50 |
| Independent Dir/Board Member | 49 |
| Corporate Officer/Principal | 47 |
| Chief Executive Officer | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Bo Jesper Hansen | 34 |
| Georges Gemayel | 33 |
| Martijn Kleijwegt | 33 |
| Anders Hedegaard | 30 |
| Rémi Droller | 29 |
| Catherine Moukheibir | 29 |
| Martin N. Bonde | 22 |
| Michael Shlomo Hove | 17 |
| Kim Stratton | 14 |
| Anders Hinsby | 14 |
| Carrolee Barlow | 12 |
| Jakob Have | 9 |
| Stephanie Okey | 9 |
| Thomas Jensen | 6 |
| Mats-Olof Wallin | 5 |
- Börse
- Insiders
- Anders Fink Vadsholt
- Unternehmensverbindungen
